Cargando…
Epirubicin-induced Kounis syndrome
BACKGROUND: Kounis syndrome is an acute coronary syndrome that appears in the setting of anaphylactic reaction or hypersensitivity. Many drugs and environmental exposures have been identified as potential offenders, and diagnosis and treatment can be challenging. CASE PRESENTATION: A 62-year-old man...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953621/ https://www.ncbi.nlm.nih.gov/pubmed/33711934 http://dx.doi.org/10.1186/s12872-021-01936-4 |
_version_ | 1783663951790211072 |
---|---|
author | Liang, Hui-zhu Zhao, Hong Gao, Jian Cao, Cheng-fu Wang, Wei-min |
author_facet | Liang, Hui-zhu Zhao, Hong Gao, Jian Cao, Cheng-fu Wang, Wei-min |
author_sort | Liang, Hui-zhu |
collection | PubMed |
description | BACKGROUND: Kounis syndrome is an acute coronary syndrome that appears in the setting of anaphylactic reaction or hypersensitivity. Many drugs and environmental exposures have been identified as potential offenders, and diagnosis and treatment can be challenging. CASE PRESENTATION: A 62-year-old man with recurrent bladder cancer underwent an intra-iliac artery epirubicin injection. After the injection, he developed chest pain and a systemic allergic reaction, with electrocardiographic alterations and elevated troponin-I levels. Emergent coronary angiography showed right coronary artery spasm and no stenosis of the other coronary arteries. This reaction was considered compatible with an allergic coronary vasospasm. A diagnosis of Kounis syndrome was made. CONCLUSIONS: Kounis syndrome is common, but a prompt diagnosis is often not possible. This case is the first to suggest that an intraarterial epirubicin injection could potentially be one of its triggers. All physicians should be aware of the pathophysiology of this condition to better recognize it and start appropriate treatment; this will prevent aggravation of the vasospastic cardiac attacks and yield a better outcome. |
format | Online Article Text |
id | pubmed-7953621 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79536212021-03-12 Epirubicin-induced Kounis syndrome Liang, Hui-zhu Zhao, Hong Gao, Jian Cao, Cheng-fu Wang, Wei-min BMC Cardiovasc Disord Case Report BACKGROUND: Kounis syndrome is an acute coronary syndrome that appears in the setting of anaphylactic reaction or hypersensitivity. Many drugs and environmental exposures have been identified as potential offenders, and diagnosis and treatment can be challenging. CASE PRESENTATION: A 62-year-old man with recurrent bladder cancer underwent an intra-iliac artery epirubicin injection. After the injection, he developed chest pain and a systemic allergic reaction, with electrocardiographic alterations and elevated troponin-I levels. Emergent coronary angiography showed right coronary artery spasm and no stenosis of the other coronary arteries. This reaction was considered compatible with an allergic coronary vasospasm. A diagnosis of Kounis syndrome was made. CONCLUSIONS: Kounis syndrome is common, but a prompt diagnosis is often not possible. This case is the first to suggest that an intraarterial epirubicin injection could potentially be one of its triggers. All physicians should be aware of the pathophysiology of this condition to better recognize it and start appropriate treatment; this will prevent aggravation of the vasospastic cardiac attacks and yield a better outcome. BioMed Central 2021-03-12 /pmc/articles/PMC7953621/ /pubmed/33711934 http://dx.doi.org/10.1186/s12872-021-01936-4 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Liang, Hui-zhu Zhao, Hong Gao, Jian Cao, Cheng-fu Wang, Wei-min Epirubicin-induced Kounis syndrome |
title | Epirubicin-induced Kounis syndrome |
title_full | Epirubicin-induced Kounis syndrome |
title_fullStr | Epirubicin-induced Kounis syndrome |
title_full_unstemmed | Epirubicin-induced Kounis syndrome |
title_short | Epirubicin-induced Kounis syndrome |
title_sort | epirubicin-induced kounis syndrome |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953621/ https://www.ncbi.nlm.nih.gov/pubmed/33711934 http://dx.doi.org/10.1186/s12872-021-01936-4 |
work_keys_str_mv | AT lianghuizhu epirubicininducedkounissyndrome AT zhaohong epirubicininducedkounissyndrome AT gaojian epirubicininducedkounissyndrome AT caochengfu epirubicininducedkounissyndrome AT wangweimin epirubicininducedkounissyndrome |